Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Emergent CDMO Case Studies: Project Design & Implementation of Fill/Finish Technologies | Contract Pharma
Breaking News

Emergent CDMO Case Studies: Project Design & Implementation of Fill/Finish Technologies

Discover new technologies that deliver large-scale yields in this case study on manufacturing therapeutics and vaccines for biopharma.

May 25, 2022 | 10:00am and 1:00pm
Jacob K. Javits Convention Center – New York, NY

REGISTER

This tour will highlight the implementation and design of the groninger FlexPro50 (non-viral) and groninger INTEGRA (viral) fill/finish expansions at two Emergent CDMO manufacturing sites in Maryland: Camden and Rockville. Tour topics include project execution by IPS and Emergent followed by the isolator-based aseptic fill/finish technologies implemented by solu-tion providers: groninger, Franz Ziel and SKAN.

Click HERE to Register

groninger manufactures fill/finish processing equipment for the pharmaceutical, cosmetics and consumer healthcare industries worldwide. For over 40 years, groninger has gained the exper-tise and experience to deliver high quality machines which meet performance demands and all relevant cGMPs. The company’s core competency is the design and manufacture of custom-ized, aseptic and nonaseptic liquid fill/finish lines and its program provides semi-automatic machines as well as the capability of fully automatic production lines and turnkey solutions.

Groninger is exhibiting at booth #2853.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters